SLITone ULTRA (ragweed allergy vaccine sublingual drops)
/ ALK-Abello
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
July 12, 2026
Comparative analysis of seven standardised commercially available grass extracts for sublingual immunotherapy in liquid formulation.
(PubMed, Allergol Immunopathol (Madr))
- "Protein content ranged from 27 to 231 µg/mL, with Apioral Forte, SlitOne Ultra and Sublivac showing similar protein profiles...The differences observed between extracts may have a relevant clinical impact. It is essential to have standardised, comparative analytical methods that allow specialists to select the most appropriate treatment."
Clinical • Journal
February 06, 2024
Rhapsody: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
(clinicaltrials.gov)
- P3 | N=445 | Completed | Sponsor: ALK-Abelló A/S | Active, not recruiting ➔ Completed
Trial completion • Allergy • Conjunctivitis • Immunology • Ocular Infections • Ocular Inflammation • Ophthalmology
May 17, 2022
Rhapsody: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
(clinicaltrials.gov)
- P3 | N=445 | Active, not recruiting | Sponsor: ALK-Abelló A/S | Recruiting ➔ Active, not recruiting
Enrollment closed • Allergy • Conjunctivitis • Immunology • Ocular Infections • Ocular Inflammation • Ophthalmology
May 19, 2021
Rhapsody: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
(clinicaltrials.gov)
- P3; N=440; Recruiting; Sponsor: ALK-Abelló A/S; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Allergy • Conjunctivitis • Immunology • Ocular Infections • Ocular Inflammation • Ophthalmology
May 11, 2021
Rhapsody: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
(clinicaltrials.gov)
- P3; N=440; Not yet recruiting; Sponsor: ALK-Abelló A/S
Clinical • New P3 trial • Allergy • Conjunctivitis • Immunology • Ocular Infections • Ocular Inflammation • Ophthalmology
1 to 5
Of
5
Go to page
1